Arthur L. Burnett, II, MD, MBA

STONY BROOK UNIVERSITY MEDICAL CENTER

HEALTH SCIENCES CENTER, L4, #060

Articles

Oral testosterone agents mark important paradigm shift

June 12, 2020

"The rigorous study and promising clinical availability of oral therapy for testosterone deficiency are flash points in the current era, in which the utility of testosterone therapy is under critical review," writes Arthur L. Burnett II, MD, MBA.

Post-prosthesis infection data alter conventional thinking

March 29, 2019

"The observations that penile prosthesis surgical infections occurring early are frequently associated with anaerobic bacterial organisms and that these infections overall comprise diverse pathogens including fungal organisms fundamentally alter conventional thinking related to this topic area," writes Arthur L. Burnett, II, MD, MBA.